Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PHY906 plus Capecitabine in Advanced Pancreatic Carcinoma
NCT00411762Phase 2Completed
- Sponsor
- Yale University
- Start
- Dec 2006
- Primary completion
- Dec 2009
- Modality
- Botanical Extract
- Countries
- 1
01
Overview
A Phase 2 trial of PHY906 in pancreatic carcinoma, sponsored by Yale University. Started Dec 2006; status: completed.
02
Drugs
PHY906
03
Conditions
pancreatic carcinoma
Beyond the preview
Go deeper on NCT00411762.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00411762.